[HTML][HTML] Why target brain adenosine receptors? A historical perspective
BB Fredholm, P Svenningsson - Parkinsonism & Related Disorders, 2020 - Elsevier
The quest for a non-dopaminergic approach to treating Parkinson's disease (PD) has been
quietly progressing over the past several decades, and is now finding its momentum. Here …
quietly progressing over the past several decades, and is now finding its momentum. Here …
[HTML][HTML] Why target brain adenosine receptors? A historical perspective
BB Fredholm, P Svenningsson - Parkinsonism & Related Disorders, 2020 - prd-journal.com
The quest for a non-dopaminergic approach to treating Parkinson's disease (PD) has been
quietly progressing over the past several decades, and is now finding its momentum. Here …
quietly progressing over the past several decades, and is now finding its momentum. Here …
Why target brain adenosine receptors? A historical perspective
BB Fredholm, P Svenningsson - Parkinsonism & related …, 2020 - pubmed.ncbi.nlm.nih.gov
The quest for a non-dopaminergic approach to treating Parkinson's disease (PD) has been
quietly progressing over the past several decades, and is now finding its momentum. Here …
quietly progressing over the past several decades, and is now finding its momentum. Here …
Why target brain adenosine receptors? A historical perspective.
BB Fredholm, P Svenningsson - Parkinsonism & Related Disorders, 2020 - europepmc.org
The quest for a non-dopaminergic approach to treating Parkinson's disease (PD) has been
quietly progressing over the past several decades, and is now finding its momentum. Here …
quietly progressing over the past several decades, and is now finding its momentum. Here …